Company / Current Assets
Integra Lifesciences Holdings Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.2B
FY2025
5-year range
$1.1B / $1.2B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#66 of 160
Health Care
What the data says
At $1.2B, Integra Lifesciences Holdings's current assets ranks #66 of 160 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $495M in FY2016 to $1.2B in FY2020.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of -1.3%.
Improved from $1.1B to $1.2B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Sector benchmark
#66 of 160 in Health CareTop 41% of 160This company $1.2B Sector average $5.2B
▼
-77.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.3%, indicating a declining trend.
- In FY2025, current assets increased 7.2% year-over-year.
- Ranks #66 out of 160 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +7.2% |
| FY2024 | $1.1B | +2.2% |
| FY2023 | $1.1B | -8.9% |
| FY2022 | $1.2B | +0.7% |
| FY2021 | $1.2B | -6.7% |
| FY2020 | $1.2B | +44.2% |
| FY2019 | $858.2M | +10.7% |
| FY2018 | $775.1M | -5.7% |
| FY2017 | $822.1M | +66.0% |
| FY2016 | $495.2M | +12.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026